Dr. Kutner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2014 - 2015
Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
CT State Medical License 2023 - 2026
NJ State Medical License 2023 - 2025
NY State Medical License 2018 - 2025
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma.Maura C Gillis, Vanessa R Weir, Cecilia Lezcano, Gopa Iyer, Allison Gordon
JAAD Case Reports. 2025-02-01 - 13 citationsManagement of immune-related cutaneous adverse events with dupilumab.Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll, Andrea P Moy, Stephen W Dusza
Journal for Immunotherapy of Cancer. 2023-06-01 - 4 citationsPancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes.Lilly Gu, Paras P Mehta, Devika Rao, Veronica Rotemberg, Marinela Capanu
Cancer Medicine. 2023-01-01
Press Mentions
Supporting Skin Health in Patients with Breast CancerMarch 11th, 2025
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
